
view our CenterWatch profile

(click on poster for more details)
We work with leading pharmaceutical companies and CROs including:
Greer Completes Enrollment for Phase III Trial in Allergy Treatment
http://www.fdanews.com/newsletter/article?articleId=108179&issueId=11731
Merck's Migraine Treatment Improves Pain in Phase III Study
http://www.fdanews.com/newsletter/article?articleId=108180&issueId=11731
Myriad Fails to Meet Endpoint With Alzheimer's Drug Candidate
http://www.fdanews.com/newsletter/article?articleId=108181&issueId=11731
DOR BioPharma Collaborates with Numoda in Phase III Clinical Trial
http://www.fdanews.com/newsletter/article?articleId=108182&issueId=11731
Vivus Gets Good News From Diabetes Drug Test
http://www.fdanews.com/newsletter/article?articleId=108183&issueId=11731
Mpex Starts Trial of Cystic Fibrosis Drug
http://www.fdanews.com/newsletter/article?articleId=108184&issueId=11731
MethylGene Launches Trial for Cancer Drug Combination
http://www.fdanews.com/newsletter/article?articleId=108185&issueId=11731
GPC Biotech Kicks Off Phase II Trial for Prostate Cancer Drug
http://www.fdanews.com/newsletter/article?articleId=108186&issueId=11731
Catalyst Starts Enrolling Patients with Methamphetamine Addiction
http://www.fdanews.com/newsletter/article?articleId=108187&issueId=11731
BioMarck Begins Phase II Clinical Study
http://www.fdanews.com/newsletter/article?articleId=108188&issueId=11731